Cancer

  • AI-powered mammography finds cancer cases not initially detected by radiologists

    Hologic has announced data form a study of of its AI-driven mammography technology, which found that the technology was able to identify cancer cases that were not initially identified by radiologists. In a retrospective study conducted at Massachusetts General Hospital, researchers analysed 5,000 digital breast tomosynthesis (3D mammography) screening exams performed between 2016 and 2019 [...]

  • Patients support AI as radiologist backup in screening mammography

    The results of a large survey from a diverse patient population revealed cautious support for artificial intelligence (AI) implementation in screening mammography, according to a new study.  While the diagnostic accuracy of AI systems has drastically improved in recent years, there is still a lack of widespread adoption and acceptance of this technology for a [...]

  • Unhealthy metabolic profile sharply increases risk of breast cancer returning

    New research shows that, in survivors of breast cancer, having an unhealthy metabolic profile or so called ‘metabolic syndrome’ increases the risk of breast cancer recurrence by 69 per cent, and subsequent breast cancer mortality by 83 per cent. Metabolic syndrome was characterised according to the American Heart Association, which includes the presence of three [...]

  • $5.5m grant to develop safer, more effective and more precise breast cancer treatment

    A promising approach to achieve safer, more effective, and more precise breast cancer treatment has earned a University of Virginia researcher a new $5.5 million grant.  Natasha Diba Sheybani, an assistant professor of biomedical engineering and research director of the Focused Ultrasound Cancer Immunotherapy Center at UVA, is pioneering an approach to metastatic breast cancer [...]

  • Study links frailty to five-year mortality rate among older women with breast cancer

    A new study links changes in frailty, a measure of decreased physiological capacity that leads to fatigue, slow walking, muscle weakness, physical inactivity, and weight loss, to five-year survival rates in older women with breast cancer. These findings suggest that managing frailty during chemotherapy could improve outcomes. The study found that 4.5 per cent of [...]

  • Researchers use ‘smart’ bomb therapy to destroy breast cancer

    Researchers in the US are collaborating to create a new light-activated “smart” bomb to treat aggressive breast cancer. The team have combined their expertise to help develop new light-sensitive chemicals called cyanine-carborane salts that are used in photodynamic therapy, or PDT, to destroy metastatic breast cancer tumours in mice with minimal side effects. Sophia Lunt [...]

  • Researchers identify key protein in breast cancer brain metastasis

    US researchers have identified a key protein whose increased presence helps promote breast cancer brain metastasis, opening a new area of research into the condition. In their recent findings, the research team found the MUC5AC protein is upregulated in patients whose cancer has spread to the brain. The finding provides a rationale for developing a new [...]

  • Ovarian cancer vaccine receives Notice of Allowance from USPTO

    Biotech company Anixa Biosciences has received a Notice of Allowance for a key patent application covering its ovarian cancer vaccine technology from the United States Patent and Trademark Office (USPTO). Anixa's ovarian cancer vaccine uses a novel approach to preventing and treating ovarian cancer, particularly among high-risk populations such as those carrying BRCA mutations or [...]

  • AI-driven platform to drive early cancer detection in dense breasts

    GE HealthCare has launched the Invenia Automated Breast Ultrasound (ABUS) Premium, a 3D ultrasound offering advanced AI features to drive faster, reproducible screening and streamline exam readings on patients with dense breasts. Approximately 71 per cent of cancers occur in dense breasts. According to studies across the U.S. and Europe, 40 per cent of women [...]

  • MIRASOL trial shows benefits for certain ovarian cancer patients

    AbbVie has announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the efficacy and safety of ELAHERE (mirvetuximab soravtansine-gynx) in women with folate receptor alpha (FRα)-positive platinum-resistant ovarian cancer (PROC) compared to chemotherapy. The results showed that at 30.5 months median follow-up, treatment with ELAHERE continued to show significant improvements in progression-free [...]